iANTHUS CAPITAL HOLDINGS (ITHUF) Common Equity (2020 - 2026)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Common Equity came in at -$116.8 million in Q1 2026, down 95.97% year-on-year from -$2.9 billion in Q1 2025, and down 13.4% quarter-over-quarter from -$103.0 million in Q4 2025.
iANTHUS CAPITAL HOLDINGS (ITHUF) Common Equity (2020 - 2026) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed Common Equity across 7 years of filings, most recently posting -$116.8 million for Q1 2026.
- Common Equity for Q1 2026 came in at -$116.8 million, down 95.97% year-over-year; the trailing twelve-month figure through Mar 2026 was -$116.8 million (down 95.97% YoY), and the FY2025 annual result was -$103.0 million, down 57.21% from the prior year.
- Common Equity came in at -$116.8 million for Q1 2026 at iANTHUS CAPITAL HOLDINGS, down from -$103.0 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $71.0 million in Q2 2022 to a low of -$116.8 million in Q1 2026.
- The 5-year median for Common Equity is -$61.7 million (2023), against an average of -$46.8 million.
- Across the five-year window, Common Equity jumped 3064.48% in 2022 and slumped 1061.36% in 2024, its largest moves.
- iANTHUS CAPITAL HOLDINGS's Common Equity stood at $11.0 million in 2022, then slumped by 661.16% to -$61.7 million in 2023, then declined by 6.29% to -$65.5 million in 2024, then tumbled by 57.21% to -$103.0 million in 2025, then decreased by 13.4% to -$116.8 million in 2026.
- The last three Common Equity figures came in at -$116.8 million (Q1 2026), -$103.0 million (Q4 2025), and -$89.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.23 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3.23 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 5.90 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 407.18 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3.41 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.50 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.75 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 446.17 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.21 Bn |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn | -116.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -116.85 Mn |
| Dec 31, 2025 | -103.04 Mn |
| Sep 30, 2025 | -89.60 Mn |
| Jun 30, 2025 | -77.92 Mn |
| Mar 31, 2025 | -59.63 Mn |
| Dec 31, 2024 | -65.54 Mn |
| Sep 30, 2024 | -93.65 Mn |
| Jun 30, 2024 | -82.44 Mn |
| Mar 31, 2024 | -73.38 Mn |
| Dec 31, 2023 | -61.67 Mn |
| Sep 30, 2023 | -43.64 Mn |
| Jun 30, 2023 | -24.90 Mn |
| Mar 31, 2023 | -6.32 Mn |
| Dec 31, 2022 | 10.99 Mn |
| Sep 30, 2022 | 53.64 Mn |
| Jun 30, 2022 | 70.98 Mn |
| Mar 31, 2022 | -32.28 Mn |
| Dec 31, 2021 | -23.64 Mn |
| Sep 30, 2021 | 1.70 Mn |
| Jun 30, 2021 | 15.92 Mn |